DVAX - Dynavax Technologies Corporation
NEXT EARNINGS:
May 4, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$27.00
DETAILS
HIGH:
$32.00
LOW:
$20.00
MEDIAN:
$29.00
CONSENSUS:
$27.00
UPSIDE:
74.19%
Market Cap:
1.82B
Volume:
5,659,539
Avg Volume:
3,161,713
52 Week Range:
9.2-15.73
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
0.93
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
405
IPO Date:
2004-02-19
EPS (TTM):
0.21
P/E Ratio:
60.81
Revenue (TTM):
277.25M
Total Assets:
986.26M
Total Debt:
254.42M
Cash & Equiv:
95.88M
Rev Growth (5Y):
51.1%
EPS Growth (5Y):
-30.3%
FCF Growth (5Y):
N/A
ROCE:
4.1%
Debt/Equity:
0.43
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.21 | $0.14 | +50.0% | $94.9M | $80.3M | +18.2% |
| 2025-08-07 | $0.14 | $0.12 | +16.7% | $95.4M | $94.0M | +1.5% |
| 2025-05-06 | $-0.11 | $0.03 | -466.7% | $68.2M | $84.2M | -19.0% |
| 2025-02-20 | $0.05 | $0.05 | 0.0% | $72.0M | $72.7M | -0.9% |
| 2024-11-07 | $0.12 | $0.11 | +9.1% | $80.6M | $71.7M | +12.4% |
| 2024-08-06 | $0.08 | $0.06 | +33.3% | $73.8M | $76.1M | -3.0% |
| 2024-05-08 | $-0.07 | $-0.05 | -40.0% | $50.8M | $55.0M | -7.6% |
| 2024-02-22 | $0.00 | $0.00 | +100.0% | $55.6M | $52.7M | +5.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 277.25M | 232.28M | 722.68M | 439.44M | 46.55M | 35.22M | 8.20M | 327,000 | 11.04M | 4.05M | 11.03M | 11.25M |
| Net Income | 27.31M | (6.39M) | 293.16M | 76.71M | (75.24M) | (152.60M) | (158.90M) | (95.15M) | (112.44M) | (106.79M) | (90.72M) | (66.72M) |
| EPS | 0.21 | -0.05 | 2.32 | 0.62 | -0.75 | -2.10 | -2.55 | -1.81 | -2.92 | -3.25 | -3.45 | -3.40 |
| Total Assets | 986.26M | 997.10M | 985.85M | 1.04B | 353.27M | 279.07M | 210.88M | 218.78M | 109.68M | 216.63M | 138.29M | 204.62M |
| Total Debt | 254.42M | 256.91M | 258.01M | 257.38M | 217.85M | 216.45M | 100.87M | 0 | 0 | 0 | 9.56M | 0 |
| Cash & Equivalents | 95.88M | 150.28M | 202.00M | 436.19M | 32.07M | 39.88M | 49.35M | 26.58M | 24.29M | 44.81M | 49.51M | 23.12M |
| Operating Cash Flow | 66.51M | 100.56M | 62.72M | 335.53M | (92.25M) | (121.25M) | (131.30M) | (77.52M) | (107.05M) | (92.56M) | (73.74M) | (58.67M) |
| Free Cash Flow | 60.16M | 96.46M | 55.58M | 326.05M | (103.32M) | (150.65M) | (146.49M) | (78.19M) | (114.81M) | (99.53M) | (75.41M) | (60.30M) |
| FCF per Share | 0.46 | 0.75 | 0.44 | 2.80 | -1.03 | -2.09 | -2.35 | -1.49 | -2.98 | -3.03 | -2.87 | -3.07 |
| Book Value | 596.80M | 622.07M | 581.01M | 222.37M | 58.69M | 8.29M | 63.06M | 199.55M | 89.20M | 187.08M | 100.48M | 186.29M |
| Cash & ST Investments | 713.83M | 742.30M | 624.39M | 545.95M | 165.04M | 151.06M | 145.54M | 191.85M | 81.42M | 196.12M | 122.65M | 189.38M |
| ROC Equity | 0.05 | -0.01 | 0.50 | 0.34 | -1.28 | -18.41 | -2.52 | -0.48 | -1.26 | -0.57 | -0.90 | -0.36 |